New brain implant aims to stop seizures before they start
NCT ID NCT05439655
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new brain implant system (CorTec Brain Interchange) in 12 people with drug-resistant epilepsy. The device records brain signals at high speed to detect abnormal activity that may lead to seizures. Unlike current devices that wait for a seizure to start, this system aims to deliver stimulation early to prevent seizures. For now, the device is used externally in the hospital to see if it can reliably capture these signals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CorTec Brain Interchange (BIC) system
What this could lead to
If successful, this could lead to a future implant that stops seizures before they start by detecting early brain signals.
What could go wrong
This is a very early feasibility study with only 12 people. The device is not yet implanted, and the main goal is just to test data recording, not health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030-3498, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States